152 related articles for article (PubMed ID: 29149829)
1. The Validation Path of Hypoxia PET Imaging: Focus on Brain Tumours.
Quartuccio N; Asselin MC
Curr Med Chem; 2018; 25(26):3074-3095. PubMed ID: 29149829
[TBL] [Abstract][Full Text] [Related]
2. Comparison of three
Dos Santos SN; Wuest M; Jans HS; Woodfield J; Nario AP; Krys D; Dufour J; Glubrecht D; Bergman C; Bernardes ES; Wuest F
Nucl Med Biol; 2023; 124-125():108383. PubMed ID: 37651917
[TBL] [Abstract][Full Text] [Related]
3. 18F-FAZA PET imaging in tumor hypoxia: A focus on high-grade glioma.
Mapelli P; Picchio M
Int J Biol Markers; 2020 Feb; 35(1_suppl):42-46. PubMed ID: 32079461
[TBL] [Abstract][Full Text] [Related]
4. Correlation between ¹⁸F-fluoromisonidazole PET and expression of HIF-1α and VEGF in newly diagnosed and recurrent malignant gliomas.
Kawai N; Lin W; Cao WD; Ogawa D; Miyake K; Haba R; Maeda Y; Yamamoto Y; Nishiyama Y; Tamiya T
Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1870-8. PubMed ID: 24781871
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia assessed by 18F-fluoromisonidazole positron emission tomography in newly diagnosed gliomas.
Yamamoto Y; Maeda Y; Kawai N; Kudomi N; Aga F; Ono Y; Nishiyama Y
Nucl Med Commun; 2012 Jun; 33(6):621-5. PubMed ID: 22422099
[TBL] [Abstract][Full Text] [Related]
6. Initial results of hypoxia imaging using 1-alpha-D: -(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole ( 18F-FAZA).
Postema EJ; McEwan AJ; Riauka TA; Kumar P; Richmond DA; Abrams DN; Wiebe LI
Eur J Nucl Med Mol Imaging; 2009 Oct; 36(10):1565-73. PubMed ID: 19430784
[TBL] [Abstract][Full Text] [Related]
7. Assessing regional hypoxia in human renal tumours using 18F-fluoromisonidazole positron emission tomography.
Lawrentschuk N; Poon AM; Foo SS; Putra LG; Murone C; Davis ID; Bolton DM; Scott AM
BJU Int; 2005 Sep; 96(4):540-6. PubMed ID: 16104907
[TBL] [Abstract][Full Text] [Related]
8. ¹⁸F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas.
Hirata K; Terasaka S; Shiga T; Hattori N; Magota K; Kobayashi H; Yamaguchi S; Houkin K; Tanaka S; Kuge Y; Tamaki N
Eur J Nucl Med Mol Imaging; 2012 May; 39(5):760-70. PubMed ID: 22307533
[TBL] [Abstract][Full Text] [Related]
9. [18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis.
Bekaert L; Valable S; Lechapt-Zalcman E; Ponte K; Collet S; Constans JM; Levallet G; Bordji K; Petit E; Branger P; Emery E; Manrique A; Barré L; Bernaudin M; Guillamo JS
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1383-1392. PubMed ID: 28315948
[TBL] [Abstract][Full Text] [Related]
10. Applying a patient-specific bio-mathematical model of glioma growth to develop virtual [18F]-FMISO-PET images.
Gu S; Chakraborty G; Champley K; Alessio AM; Claridge J; Rockne R; Muzi M; Krohn KA; Spence AM; Alvord EC; Anderson AR; Kinahan PE; Swanson KR
Math Med Biol; 2012 Mar; 29(1):31-48. PubMed ID: 21562060
[TBL] [Abstract][Full Text] [Related]
11. A Review of Hypoxia Imaging Using 18F-Fluoromisonidazole Positron Emission Tomography.
Hirata K; Watanabe S; Kitagawa Y; Kudo K
Methods Mol Biol; 2024; 2755():133-140. PubMed ID: 38319574
[TBL] [Abstract][Full Text] [Related]
12. Imaging of brain oxygenation with magnetic resonance imaging: A validation with positron emission tomography in the healthy and tumoural brain.
Valable S; Corroyer-Dulmont A; Chakhoyan A; Durand L; Toutain J; Divoux D; Barré L; MacKenzie ET; Petit E; Bernaudin M; Touzani O; Barbier EL
J Cereb Blood Flow Metab; 2017 Jul; 37(7):2584-2597. PubMed ID: 27702880
[TBL] [Abstract][Full Text] [Related]
13. New PET radiopharmaceuticals beyond FDG for brain tumor imaging.
Gulyás B; Halldin C
Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):173-90. PubMed ID: 22617239
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia positron emission tomography imaging with 18f-fluoromisonidazole.
Lee ST; Scott AM
Semin Nucl Med; 2007 Nov; 37(6):451-61. PubMed ID: 17920352
[TBL] [Abstract][Full Text] [Related]
15. 18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference Regions.
Muzi M; Peterson LM; O'Sullivan JN; Fink JR; Rajendran JG; McLaughlin LJ; Muzi JP; Mankoff DA; Krohn KA
J Nucl Med; 2015 Aug; 56(8):1223-8. PubMed ID: 26112020
[TBL] [Abstract][Full Text] [Related]
16. Assessment of hypoxia and perfusion in human brain tumors using PET with 18F-fluoromisonidazole and 15O-H2O.
Bruehlmeier M; Roelcke U; Schubiger PA; Ametamey SM
J Nucl Med; 2004 Nov; 45(11):1851-9. PubMed ID: 15534054
[TBL] [Abstract][Full Text] [Related]
17. A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using 18F-FMISO-PET.
Rockne RC; Trister AD; Jacobs J; Hawkins-Daarud AJ; Neal ML; Hendrickson K; Mrugala MM; Rockhill JK; Kinahan P; Krohn KA; Swanson KR
J R Soc Interface; 2015 Feb; 12(103):. PubMed ID: 25540239
[TBL] [Abstract][Full Text] [Related]
18. [
Guglielmo P; Quartuccio N; Rossetti V; Celli M; Alongi P; Boero M; Arnone G; Baldari S; Matteucci F; Laudicella R
Curr Med Imaging; 2022; 18(4):363-371. PubMed ID: 34533446
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the Prognostic Value of Radiomic Features in
Muzi M; Wolsztynski E; Fink JR; O'Sullivan JN; O'Sullivan F; Krohn KA; Mankoff DA
Tomography; 2020 Mar; 6(1):14-22. PubMed ID: 32280746
[TBL] [Abstract][Full Text] [Related]
20. The Roles of Hypoxia Imaging Using
Hirata K; Yamaguchi S; Shiga T; Kuge Y; Tamaki N
J Clin Med; 2019 Jul; 8(8):. PubMed ID: 31344848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
